Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.36 USD | -1.48% | -3.77% | -15.49% |
May. 16 | Everlasting momentum | |
May. 16 | Bristol Myers Gets FDA OK of Breyanzi in Follicular Lymphoma | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.49% | 87.9B | |
+34.35% | 705B | |
+31.07% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+15.45% | 238B | |
-3.23% | 210B | |
+10.36% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Transcript : Bristol-Myers Squibb Company Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-04-2024 09